TMCC2
gene geneOn this page
Also known as HUCEP11FLJ38497
Summary
TMCC2 (transmembrane and coiled-coil domain family 2, HGNC:24239) is a protein-coding gene on chromosome 1q32.1, encoding Transmembrane and coiled-coil domains protein 2 (O75069). May be involved in the regulation of the proteolytic processing of the amyloid precursor protein (APP) possibly also implicating APOE.
Involved in amyloid precursor protein metabolic process. Located in endoplasmic reticulum.
Source: NCBI Gene 9911 — RefSeq curated summary.
At a glance
- GWAS associations: 43
- Clinical variants (ClinVar): 89 total
- MANE Select transcript:
NM_014858
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24239 |
| Approved symbol | TMCC2 |
| Name | transmembrane and coiled-coil domain family 2 |
| Location | 1q32.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HUCEP11, FLJ38497 |
| Ensembl gene | ENSG00000133069 |
| Ensembl biotype | protein_coding |
| OMIM | 619429 |
| Entrez | 9911 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 7 protein_coding, 5 protein_coding_CDS_not_defined
ENST00000329800, ENST00000330675, ENST00000358024, ENST00000367159, ENST00000468846, ENST00000481950, ENST00000495538, ENST00000545499, ENST00000637895, ENST00000648708, ENST00000907462, ENST00000962349
RefSeq mRNA: 7 — MANE Select: NM_014858
NM_001242925, NM_001297611, NM_001297613, NM_001331034, NM_001375651, NM_001375652, NM_014858
CCDS: CCDS30984, CCDS55676, CCDS73010, CCDS76257, CCDS81418
Canonical transcript exons
ENST00000358024 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001443661 | 205227946 | 205228771 |
| ENSE00003569246 | 205271813 | 205273343 |
| ENSE00003595759 | 205241505 | 205242044 |
| ENSE00003596480 | 205271120 | 205271255 |
| ENSE00003606912 | 205268950 | 205269884 |
Expression profiles
Bgee: expression breadth ubiquitous, 210 present calls, max score 96.23.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.3973 / max 4159.7688, expressed in 1394 samples.
FANTOM5 promoters (11 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 8018 | 9.7395 | 1338 |
| 8024 | 4.7126 | 68 |
| 8021 | 1.0600 | 200 |
| 8019 | 0.3017 | 140 |
| 8026 | 0.2847 | 16 |
| 8027 | 0.0806 | 22 |
| 8028 | 0.0742 | 40 |
| 8020 | 0.0727 | 49 |
| 8022 | 0.0385 | 20 |
| 201897 | 0.0208 | 9 |
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 96.23 | gold quality |
| spinal cord | UBERON:0002240 | 95.41 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 95.26 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 95.12 | gold quality |
| cerebellar cortex | UBERON:0002129 | 95.05 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 94.40 | gold quality |
| amygdala | UBERON:0001876 | 94.39 | gold quality |
| cerebellum | UBERON:0002037 | 94.12 | gold quality |
| right frontal lobe | UBERON:0002810 | 94.00 | gold quality |
| prefrontal cortex | UBERON:0000451 | 93.18 | gold quality |
| cingulate cortex | UBERON:0003027 | 93.11 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 93.01 | gold quality |
| Ammon’s horn | UBERON:0001954 | 92.98 | gold quality |
| midbrain | UBERON:0001891 | 92.79 | gold quality |
| substantia nigra | UBERON:0002038 | 92.79 | gold quality |
| putamen | UBERON:0001874 | 92.76 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 92.74 | gold quality |
| hypothalamus | UBERON:0001898 | 92.71 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 92.59 | gold quality |
| nucleus accumbens | UBERON:0001882 | 92.00 | gold quality |
| ventral tegmental area | UBERON:0002691 | 91.87 | gold quality |
| pons | UBERON:0000988 | 91.53 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 91.51 | gold quality |
| frontal cortex | UBERON:0001870 | 91.48 | gold quality |
| neocortex | UBERON:0001950 | 91.35 | gold quality |
| cortical plate | UBERON:0005343 | 91.30 | gold quality |
| telencephalon | UBERON:0001893 | 91.14 | gold quality |
| caudate nucleus | UBERON:0001873 | 91.09 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 91.03 | gold quality |
| central nervous system | UBERON:0001017 | 90.88 | gold quality |
Single-cell (SCXA)
Detected in 8 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10042 | yes | 1158.88 |
| E-CURD-98 | yes | 648.32 |
| E-MTAB-9221 | yes | 11.27 |
| E-HCAD-9 | yes | 6.65 |
| E-MTAB-9067 | yes | 5.25 |
| E-CURD-112 | no | 2.10 |
| E-HCAD-10 | no | 1.89 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
83 targeting TMCC2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-345-3P | 99.89 | 70.23 | 1421 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-6857-5P | 99.87 | 65.32 | 985 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-4694-3P | 99.79 | 69.53 | 2640 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-670-5P | 99.67 | 69.94 | 1565 |
| HSA-MIR-378A-5P | 99.65 | 66.33 | 1311 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-5003-5P | 99.61 | 69.13 | 1624 |
| HSA-MIR-510-3P | 99.54 | 70.06 | 2965 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmcc2 | ENSDARG00000046007 |
| mus_musculus | Tmcc2 | ENSMUSG00000042066 |
| rattus_norvegicus | Tmcc2 | ENSRNOG00000000033 |
| drosophila_melanogaster | Dmtn | FBGN0037443 |
| caenorhabditis_elegans | WBGENE00015800 |
Paralogs (3): TMCC3 (ENSG00000057704), TMCC1 (ENSG00000172765), TEX28 (ENSG00000278057)
Protein
Protein identifiers
Transmembrane and coiled-coil domains protein 2 — O75069 (reviewed: O75069)
Alternative names: Cerebral protein 11
All UniProt accessions (2): A0A0C4DFR1, O75069
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in the regulation of the proteolytic processing of the amyloid precursor protein (APP) possibly also implicating APOE.
Subunit / interactions. May form homodimers and heterodimers with TMCC2 or TMCC3 via the coiled-coil domains. Interacts with ribosomal proteins RPL4 and RPS6. Interacts with APOE and proteolytic processed C-terminal fragment C99 of the amyloid precursor protein (APP C99).
Subcellular location. Endoplasmic reticulum membrane.
Similarity. Belongs to the TEX28 family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O75069-1 | 1 | yes |
| O75069-2 | 2 | |
| O75069-3 | 3 | |
| O75069-5 | 5 |
RefSeq proteins (7): NP_001229854, NP_001284540, NP_001284542, NP_001317963, NP_001362580, NP_001362581, NP_055673* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019394 | TEX28/TMCC | Family |
Pfam: PF10267
UniProt features (26 total): compositionally biased region 6, modified residue 6, splice variant 3, sequence conflict 3, region of interest 3, transmembrane region 2, coiled-coil region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75069-F1 | 61.98 | 0.26 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (6): 6, 163, 438, 464, 470, 503
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 168 (showing top):
MODULE_255, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, MODULE_317, IVANOVA_HEMATOPOIESIS_MATURE_CELL, GNF2_ANK1, MODULE_66, MARTINEZ_RB1_TARGETS_DN, GNF2_SPTA1, HNF1_C, GOBP_AMYLOID_PRECURSOR_PROTEIN_METABOLIC_PROCESS, CUI_TCF21_TARGETS_2_DN, VANTVEER_BREAST_CANCER_ESR1_DN, PIT1_Q6, MODULE_11
GO Biological Process (1): amyloid precursor protein metabolic process (GO:0042982)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), endomembrane system (GO:0012505), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| protein metabolic process | 1 |
| binding | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| vacuole | 1 |
| plasma membrane | 1 |
Protein interactions and networks
STRING
664 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMCC2 | APP | P05067 | 717 |
| TMCC2 | APOE | P02649 | 489 |
| TMCC2 | DSTYK | Q6XUX3 | 472 |
| TMCC2 | CORO1A | P31146 | 444 |
| TMCC2 | TSPO2 | Q5TGU0 | 407 |
| TMCC2 | TMEM81 | Q6P7N7 | 398 |
| TMCC2 | OR5M11 | Q96RB7 | 386 |
| TMCC2 | ZNF101 | Q8IZC7 | 383 |
| TMCC2 | GYPB | P06028 | 366 |
| TMCC2 | FAM241B | Q96D05 | 356 |
| TMCC2 | TEX26 | Q8N6G2 | 354 |
| TMCC2 | OR51B2 | Q9Y5P1 | 353 |
| TMCC2 | RUNDC3A | Q59EK9 | 337 |
| TMCC2 | FAM178B | Q8IXR5 | 330 |
| TMCC2 | GYPE | P15421 | 321 |
IntAct
29 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TEX28 | TMCC2 | psi-mi:“MI:0914”(association) | 0.640 |
| APOE | TMCC2 | psi-mi:“MI:0915”(physical association) | 0.590 |
| TMCC2 | APOE | psi-mi:“MI:0915”(physical association) | 0.590 |
| TMCC2 | APOE | psi-mi:“MI:0407”(direct interaction) | 0.590 |
| TMCC2 | TMCC2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KXD1 | HIP1 | psi-mi:“MI:0914”(association) | 0.530 |
| TMCC2 | CORO1A | psi-mi:“MI:0914”(association) | 0.530 |
| APP | TMCC2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TMCC2 | ADRB2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TMCC2 | SMO | psi-mi:“MI:0915”(physical association) | 0.370 |
| TMCC2 | IQUB | psi-mi:“MI:0915”(physical association) | 0.370 |
| TMCC2 | ZNF581 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TEX28 | NBAS | psi-mi:“MI:0914”(association) | 0.350 |
| TMCC2 | MARK3 | psi-mi:“MI:0914”(association) | 0.350 |
| HCN1 | USP27X | psi-mi:“MI:0914”(association) | 0.350 |
| HCN1 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| TMCC2 | RPS4Y1 | psi-mi:“MI:0914”(association) | 0.350 |
| TEX28 | PRAF2 | psi-mi:“MI:0914”(association) | 0.350 |
| TMCC1 | TMCC2 | psi-mi:“MI:0914”(association) | 0.350 |
| PTOV1 | TMCC2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| UBA1 | TMCC2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (59): TMCC2 (Two-hybrid), TMCC2 (Two-hybrid), TMCC2 (Two-hybrid), TMCC2 (Two-hybrid), TMCC2 (Two-hybrid), KAT5 (Two-hybrid), DIP2A (Two-hybrid), PRPF31 (Two-hybrid), WT1-AS (Two-hybrid), AMOTL2 (Two-hybrid), ZNF581 (Two-hybrid), FAM90A1 (Two-hybrid), ZNF250 (Two-hybrid), CCDC33 (Two-hybrid), FAM161A (Two-hybrid)
ESM2 similar proteins: A0JMF8, A2RSY1, A6QLW9, B1WAV2, B2GV50, O60271, O75069, O77627, P05412, P05627, P0C090, P17325, P22670, P48377, P48378, P48379, P48380, P48381, P56432, Q0V989, Q0V9K5, Q16656, Q32NR3, Q3KR73, Q499B3, Q49GP3, Q4R3I8, Q4R3Z4, Q4V872, Q4VGL6, Q58A65, Q5EAP5, Q5EY87, Q5RDR2, Q5RJA1, Q5TC82, Q62739, Q66IV1, Q6NRE7, Q6NUC6
Diamond homologs: O75069, O94876, Q69ZZ6, Q80W04, Q8R310, Q9ULS5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 79 |
| Likely benign | 2 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1161 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:205269883:AGG:A | donor_loss | 1.0000 |
| 1:205269885:G:A | donor_loss | 1.0000 |
| 1:205269885:G:GG | donor_gain | 1.0000 |
| 1:205271114:C:A | acceptor_gain | 1.0000 |
| 1:205271119:GGT:G | acceptor_gain | 1.0000 |
| 1:205271252:CCAG:C | donor_loss | 1.0000 |
| 1:205271253:CAG:C | donor_loss | 1.0000 |
| 1:205271255:GG:G | donor_loss | 1.0000 |
| 1:205271807:CTGCA:C | acceptor_loss | 1.0000 |
| 1:205271808:TGCA:T | acceptor_loss | 1.0000 |
| 1:205271809:GCAG:G | acceptor_loss | 1.0000 |
| 1:205271810:CAG:C | acceptor_loss | 1.0000 |
| 1:205271811:AGG:A | acceptor_loss | 1.0000 |
| 1:205271812:G:GC | acceptor_loss | 1.0000 |
| 1:205228767:TAAAG:T | donor_loss | 0.9900 |
| 1:205228768:AAAGG:A | donor_loss | 0.9900 |
| 1:205228769:AAGG:A | donor_loss | 0.9900 |
| 1:205228771:GGT:G | donor_loss | 0.9900 |
| 1:205228772:GTGA:G | donor_loss | 0.9900 |
| 1:205228773:T:A | donor_loss | 0.9900 |
| 1:205241503:A:G | acceptor_gain | 0.9900 |
| 1:205242040:ACAAG:A | donor_loss | 0.9900 |
| 1:205242041:CAAGG:C | donor_loss | 0.9900 |
| 1:205242042:AAGG:A | donor_loss | 0.9900 |
| 1:205242043:AGG:A | donor_loss | 0.9900 |
| 1:205242044:GGTGA:G | donor_loss | 0.9900 |
| 1:205242045:GT:G | donor_loss | 0.9900 |
| 1:205242046:T:G | donor_loss | 0.9900 |
| 1:205268947:CAG:C | acceptor_loss | 0.9900 |
| 1:205268948:AGGTC:A | acceptor_gain | 0.9900 |
AlphaMissense
4626 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:205269077:T:C | L292P | 1.000 |
| 1:205269151:T:C | Y317H | 1.000 |
| 1:205269151:T:G | Y317D | 1.000 |
| 1:205269152:A:C | Y317S | 1.000 |
| 1:205269152:A:G | Y317C | 1.000 |
| 1:205269155:T:C | L318P | 1.000 |
| 1:205269161:T:C | L320P | 1.000 |
| 1:205269201:G:C | K333N | 1.000 |
| 1:205269201:G:T | K333N | 1.000 |
| 1:205269208:T:C | F336L | 1.000 |
| 1:205269209:T:C | F336S | 1.000 |
| 1:205269209:T:G | F336C | 1.000 |
| 1:205269210:C:A | F336L | 1.000 |
| 1:205269210:C:G | F336L | 1.000 |
| 1:205269220:A:G | N340D | 1.000 |
| 1:205269251:T:C | L350P | 1.000 |
| 1:205269263:T:C | L354P | 1.000 |
| 1:205269497:T:A | I432N | 1.000 |
| 1:205269866:T:C | L555P | 1.000 |
| 1:205269878:G:C | R559P | 1.000 |
| 1:205271128:G:C | R564P | 1.000 |
| 1:205271131:T:C | L565P | 1.000 |
| 1:205271140:A:C | Q568P | 1.000 |
| 1:205271143:T:C | L569P | 1.000 |
| 1:205271152:T:C | L572P | 1.000 |
| 1:205271161:T:C | L575P | 1.000 |
| 1:205271163:C:G | H576D | 1.000 |
| 1:205271167:A:C | Q577P | 1.000 |
| 1:205271185:T:C | L583P | 1.000 |
| 1:205271197:T:C | L587P | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000010210 (1:205273346 C>T), RS1000093790 (1:205231540 T>A), RS1000282860 (1:205262402 G>A), RS1000358808 (1:205255270 C>T), RS1000366659 (1:205249529 CT>C), RS1000392189 (1:205243191 C>G), RS1000440140 (1:205249710 C>G), RS1000446408 (1:205230745 TGG>T), RS1000535081 (1:205249965 G>A,C), RS1000619598 (1:205256461 C>T), RS1000702874 (1:205248330 G>A), RS1000775067 (1:205264069 T>C), RS1000827480 (1:205248479 C>T), RS1000949657 (1:205250287 T>C), RS1001012956 (1:205260978 C>G,T)
Disease associations
OMIM: gene MIM:619429 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
43 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000497_7 | Mean platelet volume | 1.000000e-20 |
| GCST001335_7 | Mean platelet volume | 4.000000e-27 |
| GCST001337_3 | Platelet count | 3.000000e-14 |
| GCST002184_3 | Mean platelet volume | 3.000000e-13 |
| GCST004599_262 | Mean platelet volume | 7.000000e-76 |
| GCST004599_263 | Mean platelet volume | 1.000000e-210 |
| GCST004602_24 | Mean corpuscular volume | 4.000000e-20 |
| GCST004605_75 | Mean corpuscular hemoglobin concentration | 2.000000e-20 |
| GCST004611_1 | High light scatter reticulocyte count | 1.000000e-23 |
| GCST004612_158 | High light scatter reticulocyte percentage of red cells | 4.000000e-20 |
| GCST004616_122 | Platelet distribution width | 4.000000e-11 |
| GCST004619_214 | Reticulocyte fraction of red cells | 4.000000e-10 |
| GCST004628_136 | Immature fraction of reticulocytes | 5.000000e-27 |
| GCST004630_18 | Mean corpuscular hemoglobin | 2.000000e-33 |
| GCST005993_65 | Mean corpuscular hemoglobin | 1.000000e-10 |
| GCST010143_34 | Meat-related diet | 1.000000e-08 |
| GCST010143_9 | Meat-related diet | 4.000000e-11 |
| GCST010697_12 | Cortical surface area (min-P) | 6.000000e-10 |
| GCST010698_16 | Subcortical volume (min-P) | 8.000000e-09 |
| GCST010699_52 | Brain morphology (min-P) | 5.000000e-08 |
| GCST010700_66 | Cortical thickness (MOSTest) | 3.000000e-09 |
| GCST010701_17 | Cortical surface area (MOSTest) | 5.000000e-08 |
| GCST010702_2 | Subcortical volume (MOSTest) | 3.000000e-08 |
| GCST010703_27 | Brain morphology (MOSTest) | 5.000000e-09 |
| GCST90002380_120 | Basophil percentage of white cells | 6.000000e-10 |
| GCST90002385_103 | High light scatter reticulocyte count | 3.000000e-58 |
| GCST90002386_389 | High light scatter reticulocyte percentage of red cells | 2.000000e-47 |
| GCST90002387_241 | Immature fraction of reticulocytes | 8.000000e-44 |
| GCST90002387_242 | Immature fraction of reticulocytes | 2.000000e-16 |
| GCST90002390_334 | Mean corpuscular hemoglobin | 1.000000e-37 |
EFO canonical traits (13, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004309 | platelet count |
| EFO:0004528 | mean corpuscular hemoglobin concentration |
| EFO:0007986 | reticulocyte count |
| EFO:0007984 | platelet component distribution width |
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
| EFO:0007992 | basophil percentage of leukocytes |
| EFO:0005091 | monocyte count |
| EFO:0004833 | neutrophil count |
| EFO:0004305 | erythrocyte count |
| EFO:0009188 | Red cell distribution width |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
38 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation, increases expression | 3 |
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| trichostatin A | affects expression | 1 |
| sulforaphane | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| zinc chromate | decreases expression, increases abundance | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| HC toxin | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression, decreases reaction | 1 |
| 15-acetyldeoxynivalenol | increases expression | 1 |
| chromium hexavalent ion | decreases expression, increases abundance | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| oxamflatin | increases expression | 1 |
| apicidin | increases expression | 1 |
| scriptaid | increases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Panobinostat | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Amiodarone | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Caffeine | increases expression | 1 |
| Cisplatin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.